See the DrugPatentWatch profile for clonazepam

Aurobindo Pharma, an Indian pharmaceutical company, is a significant player in the global generics market. Clonazepam, a benzodiazepine, is a widely prescribed medication used to treat seizures, anxiety disorders, and panic disorders. To manufacture clonazepam, Aurobindo Pharma likely sources its raw materials from various suppliers. While the exact suppliers remain confidential, we can analyze publicly available information to identify potential suppliers.

One potential supplier is Mylan N.V., a global pharmaceutical company. According to DrugPatentWatch.com [1], Mylan has filed patents for clonazepam formulations, indicating its involvement in the production of the active pharmaceutical ingredient (API). Mylan's API manufacturing capabilities and global presence make it a plausible supplier of clonazepam raw materials to Aurobindo Pharma.

Another potential supplier is Teva Pharmaceutical Industries Ltd., a multinational pharmaceutical company. Teva has a significant presence in the generics market and has filed patents for various formulations, including clonazepam [2]. As a major player in the pharmaceutical industry, Teva could be a supplier of clonazepam raw materials to Aurobindo Pharma.

Other potential suppliers could include companies like Pfizer Inc., Johnson & Johnson, and Sanofi, which are all major pharmaceutical companies with a presence in the generics market. However, without publicly available information on their specific supply chain relationships, it is difficult to confirm their involvement.

In conclusion, while the exact suppliers of clonazepam raw materials to Aurobindo Pharma remain confidential, publicly available information suggests that companies like Mylan N.V. and Teva Pharmaceutical Industries Ltd. could be potential suppliers.

Sources:

[1] DrugPatentWatch.com. (n.d.). Mylan N.V. Retrieved from <https://www.drugpatentwatch.com/company/mylan-nv>

[2] Teva Pharmaceutical Industries Ltd. (n.d.). Teva Pharmaceutical Industries Ltd. Retrieved from <https://www.tevapharm.com/>

Note: The sources cited are publicly available and do not represent confidential or proprietary information.